Brief: Transgene Launches Capital Increase Via Private Placement Of 32 Million Euros
June 21 (Reuters) - Transgene SA TRNG.PA :
* LAUNCHES CAPITAL INCREASE VIA PRIVATE PLACEMENT OF EUR 32
MILLION
* HISTORICAL SHAREHOLDERS TO PARTICIPATE IN UP TO 80% OF
CAPITAL
INCREASE
* FUNDS RAISED WILL ALLOW TRANSGENE TO PURSUE AMBITIOUS
CLINICAL
DEVELOPMENT PLAN AND EXTEND FINANCIAL VISIBILITY UNTIL Q4 OF
2023
Source text for Eikon: ID:nNDL6LlNzG
Further company coverage: TRNG.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Transgene SA
See all newsFrance's Transgene H1 operating income falls on lower tax credit
Transgene jumps 20% on positive cancer vaccine data in early trial
Brief: Transgene & NEC Bio Sign License Agreement To Prepare Next Steps Of Development Of TG4050 In Head & Neck Cancer
Brief: Transgene SA Says Myvac Platform To Initiate Phase 1 Trial In Second Indication In 2026
France's Transgene 2025 net loss widens on higher financial costs